Back to
Woodline Partners LP
KYMR
23 quarters
Position history for
Woodline Partners LP's holdings in Kymera Therapeutics, Inc.
Yes. Woodline Partners holds 500,868 shares of KYMR (Kymera Therapeutics), worth $57.4M, as of its Q2 2026 13F filing. It increased the position by 297,283 shares (+146.0%) from Q1 2026. Woodline Partners has held KYMR since Q2 2022, across 17 quarterly 13F filings. KYMR is 0.2% of Woodline Partners' reported 13F portfolio.
Current Value
$57.4M
Current Shares
500,868
Total Value Change
+$52.1M
Total Shares Change
+334,651
Quarter-by-Quarter History
Other major holders of KYMR: FMR LLC, Baker Bros. Advisors LP, Avoro Capital Advisors LLC, T. Rowe Price Associates, Inc.